Search

everythinglearnresearchcommunity

for

Search:↓

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Finasteride slightly improves prostate symptoms but has minimal difference from placebo.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.